[ad_1]
One analyst doesn’t see a “realistic bear-case for Netflix in the foreseeable future” given Netflix’s recent subscriber performance and fundamental strength.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...